95 related articles for article (PubMed ID: 3127585)
1. The cost effectiveness of auranofin: results of a randomized clinical trial.
Thompson MS; Read JL; Hutchings HC; Paterson M; Harris ED
J Rheumatol; 1988 Jan; 15(1):35-42. PubMed ID: 3127585
[TBL] [Abstract][Full Text] [Related]
2. Dose response studies and longterm evaluation of auranofin in rheumatoid arthritis.
Champion GD; Cairns DR; Bieri D; Adena MA; Browne CD; Cohen ML; Day RO; Edmonds JP; Graham GG; de Jager J
J Rheumatol; 1988 Jan; 15(1):28-34. PubMed ID: 3280795
[TBL] [Abstract][Full Text] [Related]
3. Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine.
Leonard PA; Bienz SR; Clegg DO; Ward JR
J Rheumatol; 1987 Feb; 14(1):55-9. PubMed ID: 3106632
[TBL] [Abstract][Full Text] [Related]
4. Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study.
Borg G; Allander E; Lund B; Berg E; Brodin U; Pettersson H; Trang L
J Rheumatol; 1988 Dec; 15(12):1747-54. PubMed ID: 14552308
[TBL] [Abstract][Full Text] [Related]
5. [Clinical effectiveness and tolerance of auranofin in patients with chronic polyarthritis. Results of a multicenter long-term study].
Klein G; Schwann H; Mirtl B; Thumb N; Mayerhofer F; Singer F; Tausch G; Gaismayer K; Rieder H; Hartweger A
Z Rheumatol; 1988; 47(5):342-6. PubMed ID: 3149087
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy and safety of auranofin: a review of clinical experience.
Blodgett RC; Pietrusko RG
Scand J Rheumatol Suppl; 1986; 63():67-78. PubMed ID: 3110943
[TBL] [Abstract][Full Text] [Related]
7. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
Ogrendik M
Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
[TBL] [Abstract][Full Text] [Related]
9. Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial.
Bombardier C; Ware J; Russell IJ; Larson M; Chalmers A; Read JL
Am J Med; 1986 Oct; 81(4):565-78. PubMed ID: 3532786
[TBL] [Abstract][Full Text] [Related]
10. Double-blind randomized trial of diclofenac sodium versus placebo in patients with rheumatoid arthritis.
Weisman MH
Clin Ther; 1986; 8(4):427-38. PubMed ID: 3524843
[TBL] [Abstract][Full Text] [Related]
11. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study.
Schattenkirchner M; Kaik B; Muller-Fassbender H; Rau R; Zeidler H
J Rheumatol Suppl; 1982; 8():184-9. PubMed ID: 6813483
[TBL] [Abstract][Full Text] [Related]
12. [A multicenter cross-sectional study on the health related quality of life of patients with rheumatoid arthritis using a revised Japanese version of the arthritis impact measurement scales version 2 (AIMS 2), focusing on the medical care costs and their associative factors].
Hashimoto A; Sato H; Nishibayahi Y; Shiino Y; Kutsuna T; Ishihara Y; Hoshi K; Fujimori J; Tsuboi S; Kondo H; Akizuki M; Moroi Y; Yoshida S
Ryumachi; 2002 Feb; 42(1):23-39. PubMed ID: 11925904
[TBL] [Abstract][Full Text] [Related]
13. Economic evaluation of oral valdecoxib versus diclofenac in the treatment of patients with rheumatoid arthritis in a randomized clinical trial.
von Scheele B; Peña B; Wong J; Niculescu L
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii53-9. PubMed ID: 14585918
[TBL] [Abstract][Full Text] [Related]
14. Postmarketing experience with auranofin in the Federal Republic of Germany.
Schattenkirchner M; Missler B; Mulz D
Scand J Rheumatol Suppl; 1986; 63():57-66. PubMed ID: 3299683
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of auranofin as demonstrated by improvement in clinical parameters and decrease in anti-inflammatory usage: a long-term, multicenter study.
Brenol JC; Chahade W; De Freitas GG; De Pádua PM; Rachid A; Samara A; Seda H; Ximenes AC
Scand J Rheumatol Suppl; 1986; 63():37-45. PubMed ID: 3299682
[TBL] [Abstract][Full Text] [Related]
16. Cost effectiveness of etanercept (Enbrel) in combination with methotrexate in the treatment of active rheumatoid arthritis based on the TEMPO trial.
Kobelt G; Lindgren P; Singh A; Klareskog L
Ann Rheum Dis; 2005 Aug; 64(8):1174-9. PubMed ID: 15708879
[TBL] [Abstract][Full Text] [Related]
17. [Comparative effectiveness of chrysanol and auranofin in rheumatoid arthritis].
Atakhodzhaeva ZA; Sigidin IaA
Ter Arkh; 1987; 59(12):30-3. PubMed ID: 3328906
[TBL] [Abstract][Full Text] [Related]
18. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis.
Katz WA; Alexander S; Bland JH; Blechman W; Bluhm GB; Bonebrake RA; Falbo A; Greenwald RA; Hartman S; Hobbs T; Indenbaum S; Lergier JE; Lanier BG; Lightfoot RW; Phelps P; Sheon RP; Torretti D; Wenger ME; Wilske K
J Rheumatol Suppl; 1982; 8():173-8. PubMed ID: 6813481
[TBL] [Abstract][Full Text] [Related]
20. Short-term study of indoprofen in comparison with placebo and indomethacin in rheumatoid arthritis.
Delbarre F
Eur J Rheumatol Inflamm; 1981; 4(1):66-73. PubMed ID: 7042364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
